Charles A. Reinhart, III

2019

In 2019, Charles A. Reinhart, III earned a total compensation of $1.4M as Chief Financial Officer at Pacira Pharmaceuticals, a 1% decrease compared to previous year.

Compensation breakdown

Bonus$195,000
Option Awards$560,952
Salary$433,512
Stock Awards$191,576
Other$8,704
Total$1,389,744

Reinhart received $561K in option awards, accounting for 40% of the total pay in 2019.

Reinhart also received $195K in bonus, $433.5K in salary, $191.6K in stock awards and $8.7K in other compensation.

Rankings

In 2019, Charles A. Reinhart, III's compensation ranked 7,712th out of 13,971 executives tracked by ExecPay. In other words, Reinhart earned more than 44.8% of executives.

ClassificationRankingPercentile
All
7,712
out of 13,971
45th
Division
Manufacturing
3,011
out of 5,695
47th
Major group
Chemicals And Allied Products
1,130
out of 2,194
49th
Industry group
Drugs
964
out of 1,880
49th
Industry
Pharmaceutical Preparations
714
out of 1,392
49th

Pay ratio

Charles A. Reinhart, III's Pay$1,389,744
Median Employee's Pay$155,462
Pay Ratio

9

to 1

In 2019, the annual total compensation of Charles A. Reinhart, III was $1,389,744.

The annual total compensation of the median employee at Pacira Pharmaceuticals was $155,462.

The ratio of Charles A. Reinhart, III's pay to the pay of median employee was therefore 9 to one.

Source: SEC filing on April 24, 2020.

Reinhart's colleagues

We found four more compensation records of executives who worked with Charles A. Reinhart, III at Pacira Pharmaceuticals in 2019.

2019

David Stack

Pacira Pharmaceuticals

Chief Executive Officer

2019

Max Reinhardt

Pacira Pharmaceuticals

President

2019

Kristen Williams

Pacira Pharmaceuticals

Chief Administrative Officer

2019

Roy Winston

Pacira Pharmaceuticals

Chief Clinical Officer

News

You may also like